Publications by authors named "G Reichmann"
Background: Healthcare corruption poses a significant threat to individuals, institutions, sectors, and states. Combating corruption is paramount for protecting patients, maintaining the healthcare system's integrity, and preserving public trust. As corruption evolves, takes new forms, and adapts to changing socio-political landscapes, understanding its manifestations is critical to developing effective anti-corruption strategies at individual and institutional levels.
View Article and Find Full Text PDFIn this article, we discuss possibilities for ranking business schools and analyse the stability of research rankings using different ranking methods. One focus is set on a comparison of publication-based rankings with citation-based rankings. Our considerations and discussions are based on a (small) case study for which we have examined all (six) business schools at public universities in Austria.
View Article and Find Full Text PDFArticle Synopsis
- Chronic pain, specifically Chronic Pelvic Pain (CPP), significantly complicates opioid use disorder (OUD), with overlapping psychosocial and neurobiological risks.
- The study aimed to compare the prevalence of CPP and sexual dysfunction between individuals on buprenorphine for OUD and those receiving treatment for other chronic medical conditions, using various assessment tools.
- Findings indicated high levels of CPP and sexual dysfunction in both groups, highlighting the need for integrated, gender-sensitive approaches in OUD treatment to improve recovery outcomes.
A major objective of health policy in many countries is to avoid inequality in the distribution of health care resources. Our goal is to provide initial insight into the inequality in the regional distribution of different health care resources per capita and the variation of the inequality over time in Austria to provide starting points for policy recommendations and international comparisons. We also aim to examine whether the type of inequality measure and need-adjustment has an impact on the results.
View Article and Find Full Text PDFArticle Synopsis
- TNFα is crucial in the development of autoimmune diseases, and therapies targeting it, like neutralizing antibodies, are important but can increase the risk of infections, particularly from leishmaniasis.
- A study using infected human macrophages and T-cells highlighted that certain anti-TNFα treatments, specifically Humira and Remicade, reduce T-cell activity and worsen macrophage infections, while Cimzia does not have these negative effects.
- Cimzia's effectiveness may be due to its PEGylated form, which enhances parasite control and increases levels of complement component C5a, suggesting it could be a safer TNFα therapy for regions where leishmaniasis is common.